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Abstract
Background: Lower maternal serum vitamin B12 (B12) and folate levels have been asso-
ciated with lower offspring birthweight, in observational studies. The aim of this study
was to investigate whether this relationship is causal.
Methods: We performed two-sample Mendelian randomization (MR) using summary
data on associations between genotype-B12 (10 genetic variants) or genotype-folate
(four genetic variants) levels from: a genome-wide association study of 45 576 individu-
als (sample 1); and both maternal- and fetal-specific genetic effects on offspring birth-
weight from the latest Early Growth Genetics consortium meta-analysis with 297 356
individuals reporting their own birthweight and 210 248 women reporting their
offspring’s birthweight (sample 2). We used the inverse variance weighted method,
and sensitivity analyses to account for pleiotropy, in addition to excluding a potentially
pleiotropic variant in the FUT2 gene for B12 levels.
Results: We did not find evidence for a causal effect of maternal or fetal B12 levels on off-
spring birthweight. The results were consistent across the different methods. We found a
positive causal effect of maternal folate levels on offspring birthweight [0.146 (0.065,
0.227), which corresponds to an increase in birthweight of 71 g per 1 standard deviation
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higher folate]. We found some evidence for a small inverse effect of fetal folate levels on
their own birthweight [0.051 (0.100, 0.003)].
Conclusions: Our results are consistent with evidence from randomized controlled trials
that higher maternal folate levels increase offspring birthweight. We did not find evi-
dence for a causal effect of B12 levels on offspring birthweight, suggesting previous ob-
servational studies may have been confounded.
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Background
Low birthweight is not only associated with lower infant
survival, but also increased future risk of chronic diseases
in offspring such as type two diabetes mellitus and cardio-
vascular disease. The Developmental Origins of Health
and Disease (DOHaD) hypothesis provides an explanation
for these robust observational associations,1–6 stipulating
that impaired fetal growth and development in utero lead
to developmental compensations that programme the off-
spring to increased risk of disease in later life.4 In other
words, maternal under- or overnutrition during pregnancy
not only exerts detrimental effects on offspring birth-
weight, but is hypothesized to cause long-term effects on
the cardiometabolic health of the offspring. Therefore,
identifying causal relationships between maternal nutrition
and offspring birthweight could provide information on
modifiable maternal exposures to ensure that more babies
are born within a healthy weight range.
Low maternal folate (vitamin B9) and vitamin B12 lev-
els have previously been linked with low offspring birth-
weight and increased risk of preterm birth.7–11 The
combination of high folate and low vitamin B12 levels has
also been associated with low birthweight.12 However, the
association between B12 levels and offspring birthweight
has been questioned, with a systematic review and meta-
analysis showing no evidence for an association [5.1 g
change in birthweight per 1 standard deviation (SD) in-
crease in B12 levels (95% confidence interval: 10.9 g,
21.0 g)].13 For folate, data from a meta-analysis suggested
a 2% (95% confidence interval: 0.7%, 3.5%) higher birth-
weight for every 2-fold higher folate intake,8 and a
Cochrane review suggested a 135 g (95% confidence inter-
val: 47.85 g, 223.68 g) increase in birthweight with folic
acid supplement use.14 However, the observational associ-
ation between maternal folate and B12 levels and offspring
birthweight could be confounded by other maternal char-
acteristics, such as high body mass index (BMI) and gesta-
tional diabetes.
To ensure pregnant women have adequate levels of fo-
late during their pregnancy to prevent neural tube defects,
folic acid supplements are recommended to all women
planning pregnancy and during the antenatal period. In ad-
dition, many countries fortify certain foods with folic acid.
For vitamin B12 recommendations vary, with most high-
income countries not recommending supplements unless
there is clear deficiency. Folate and B12, along with vita-
min B6 and B2, are coenzymes or integral components of
coenzymes that are involved in one-carbon metabolism,
also known as the folate metabolism pathway.15 One-
carbon metabolism is essential for DNA synthesis and
DNA methylation,15,16 which is particularly important
during pregnancy because of the cell division and differen-
tiation occurring in utero. The interplay between folate
and B12 is important, both because a folate deficiency can
be induced by a B12 deficiency17 and because high folate
levels can mask a B12 deficiency.18 The interrelationship
Key Messages
• We show that maternal two-sample Mendelian randomization can be used to identify potential causal effects of ma-
ternal exposures on offspring outcomes.
• Our study finds that higher maternal folate levels across the distribution increase offspring mean birthweight, in ac-
cordance with previous randomized controlled trials.
• We did not find evidence for a causal effect of maternal B12 levels on offspring birthweight, suggesting previous ob-
servational studies may have been confounded.
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between these two vitamins is best explained by the methyl
trap hypothesis. This hypothesis states that a vitamin B12
deficiency can lead to lowered levels of methionine synthe-
tase, which results in a functional folate deficiency by trap-
ping an increased proportion of folate as the 5-methyl
derivative.17 Low folate and B12 levels may be caused by
low dietary intake, lack of intrinsic factor needed to absorb
vitamin B12, poor absorption of ingested folate/B12 or an
alteration of folate metabolism due to genetic defects or
drug interactions.
Conclusions regarding causality cannot easily be drawn
from observational multivariable regression association
studies. Mendelian randomization (MR) is a method that
uses genetic variants as instrumental variables to provide
information on causality in observational studies.19
Offspring birthweight is thought to be influenced by off-
spring genetics, maternal genetics operating on the intra-
uterine environment, and environmental factors. MR
investigating the effect of maternal environmental expo-
sures on offspring birthweight is therefore more compli-
cated, because we have both maternal and offspring
genetics (which are correlated, r0.5) influencing the out-
come of interest. A recently described statistical method,
based on structural equation modelling, can be used to esti-
mate the independent effect of maternal genotypes on off-
spring outcomes by conditioning on offspring genotype.20
These maternal-specific genetic effects can then be used in
a two-sample MR framework to estimate the causal effect
of maternal environmental exposures, such as B12 or fo-
late levels, on offspring birthweight.21 The aim of this
study was to investigate whether there is a causal relation-
ship between serum levels of maternal B12 or folate and
offspring birthweight.
Methods
Publicly available summary results statistics (effect esti-
mates and their standard errors for each SNP’s effect on
birthweight, folate levels and B12 levels) were used for the
main Mendelian randomization analysis and therefore no
additional ethics approval was required. Ethical approval
for the Exeter Family of Childhood Health was given by
the North and East Devon (UK) Local Research Ethics
Committee (approval number 1104), and informed con-
sent was obtained from the parents of the newborns.
23andMe data (used in the maternal gestational age analy-
sis) were collected in compliance with all applicable laws,
from human subjects under an Institutional Review Board-
approved protocol in accordance with US federal guide-
lines for ‘Protection of Human Subjects’, and the 23andMe
activities described herein fall within the scope of the
approved protocol. Only aggregate, anonymized data were
provided from 23andMe for analysis in this study.
Exposure measurements
We extracted summary results data on 10 single nucleotide
polymorphisms (SNPs) that were robustly associated with
serum B12 levels and four SNPs that were robustly associ-
ated with folate levels, in the largest genome-wide associa-
tion study (GWAS) of these phenotypes to date22
(N¼ 45 576 individuals of Danish and Icelandic ancestry;
Supplementary Table S1, available as Supplementary data
at IJE online). The FUT6 variant, rs7788053, was identi-
fied in the GWAS as associated with B12 levels but was
not included in our analysis, as it is monoallelic in the CEU
(Utah Residents from North and West Europe) [https://
ldlink.nci.nih.gov/] population. The SNP was not available
in the GWAS of birthweight and therefore was left out of
the analysis.
We obtained summary results data from the two Danish
cohorts in the GWAS (N¼ 8424) for the 10 SNPs associ-
ated with B12 levels and four SNPs associated with folate
levels. Due to the interplay between folate and B12 levels,
we used these data to investigate the causal effect of B12
levels on folate levels and of folate levels on B12 levels.
Outcome measurements
We obtained summary results statistics from the latest
GWAS of birthweight published by the Early Growth
Genetics (EGG) consortium,23 which included full-term
births (defined as 37 or more weeks of gestation where ges-
tational age was available, or a birthweight of 2.5–4.5 kg
for UK Biobank). The GWAS of birthweight included
297 356 individuals reporting their own birthweight and
210 248 women reporting their offspring’s birthweight.
Due to the correlation between maternal and fetal geno-
types, and the influence of both genotypes on offspring
birthweight, the authors used a structural equation
model20 to estimate the independent maternal and fetal ge-
netic effects on birthweight (this model is similar to a con-
ditional linear model, accounting for both maternal and
fetal genotypes). We extracted publicly available summary
results data for the maternal- and fetal-specific effects on
birthweight, generated using the structural equation mod-
els as described by Warrington and colleagues,23 published
online by the EGG consortium [https://egg-consortium.
org/birth-weight-2019.html] (Supplementary Table S2,
available as Supplementary data at IJE online). The
MMACHC SNP, rs12272669, which is associated with
B12 levels, was not available in the GWAS summary
results statistics for birthweight, so we extracted an SNP in
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high linkage disequilibrium (LD), rs11234541
(R2¼ 0.942, D’¼ 1) [https://ldlink.nci.nih.gov/].
In the folate GWAS, the MTHFR SNP, rs17421511,
was identified to be associated with folate in an analysis
that conditioned on another MTHFR SNP, rs1801133.
Therefore, we performed an approximate conditional and
joint (COJO) analysis24 in genome-wide complex trait
analysis (GCTA)25 using European ancestry meta-analysis
summary statistics for the maternal- and fetal-specific
effects on birthweight, conditioning on rs1801133. The
reference panel for determining LD was made up of 47 674
unrelated UK Biobank participants defined by the UK
Biobank as having British ancestry.26 Unrelated individuals
with British ancestry were identified on the basis of iden-
tity by descent (IBD) sharing of <0.1, and from there a
random sample of individuals with identity by state (IBS)
<0.025 were selected as the reference panel. We extracted
the maternal- and fetal-specific effect estimates for
rs17421511 from the COJO analysis (Supplementary
Table S2).
Statistical analysis
To assess instrument strength for the standard inverse vari-
ance weighted (IVW) MR analysis, we calculated the ap-
proximate F statistics for each of the folate and B12 SNPs
that will be used in our two-sample MR study [i.e. F  (b/
SE)2] (Supplementary Table S1). In the case of MR Egger
regression analysis,27 the F statistics from the individual
markers are not a sufficient indicator of instrument
strength. Rather, Bowden and colleagues28 show that an
I2GX statistic can be used to quantify instrument strength in
MR Egger analyses. The authors show that a high value of
I2GX (i.e. close to one) suggests that the instrument effect
sizes are estimated well and that measurement error/weak
instrument bias is unlikely to affect the results of standard
MR Egger analyses. On the other hand, if I2GX is less than
0.9, inference from MR Egger should be interpreted with
caution and some alternative sensitivity analyses should be
considered. As such, we calculated I2GX values for our SNPs
to assess the instrument strength in the MR Egger analysis.
We performed two-sample, IVW MR analysis to esti-
mate the causal effect of maternal B12 or folate levels on
offspring birthweight. We performed a secondary analysis
investigating the causal relationship between an individu-
al’s own B12 or folate levels and their own birthweight, us-
ing the results of the fetal-specific genetic effects on
birthweight. Analyses were performed with the
TwoSampleMR package29 [https://github.com/MRCIEU/
TwoSampleMR] in R version 3.5.2 [https://cran.r-project.
org/]. We performed a test of heterogeneity of causal effect
estimates across each of the SNPs using Cochran’s Q. If
heterogeneity was detected, leave-one-out IVW analysis
was performed to assess the effect of the individual SNPs
on the overall causal estimate. We tested for directional
pleiotropy using the MR Egger intercept.27 Additionally,
we conducted sensitivity analysis to adjust for any direc-
tional pleiotropy, using MR Egger regression,27 weighted
median,30 simple and weighted mode estimation.31 We ac-
knowledge that these sensitivity analyses perform well
with large numbers of SNPs and may not perform well in
our analyses for effects of folate where we only have four
SNPs; however, we include the results of the MR Egger for
completeness. As the weighted and simple mode estimator
select the group of SNPs that produce the most common
causal effect on the outcome, we chose not to perform
these analysis for folate where only four SNPs were
available.
Further sensitivity analyses were conducted for the B12
analysis excluding the FUT2 variant, rs602662. The FUT2
protein, which is expressed in the small intestine, is a part
of the protein glycosylation pathway and is involved in the
absorption and modification of several nutrients.32–34
Therefore it may reflect nutritional status, which in turn
could affect a multitude of lifestyle-associated traits and
diseases. In a previous MR study investigating the causal
relationship between B12 and BMI,35 the causal relation-
ship identified between low B12 levels and higher BMI at-
tenuated to the null when the variant in the FUT2 gene
was excluded from the analysis.35 We therefore performed
the MR analyses both with and without the FUT2 variant,
to assess the effect of this potentially pleiotropic variant on
the causal estimate, as has been done in previous
papers.35,36
Three of the variants associated with folate levels were
located within the MTHFR gene. We looked up the LD be-
tween the variants (Supplementary Table S3, available as
Supplementary data at IJE online) and conducted a leave-
one-out MR analysis as a sensitivity analysis to assess the
influence of the individual SNPs.
Finally, we performed IVW MR analysis and sensitivity
analyses to adjust for directional pleiotropy, to assess the
causal effect of B12 levels on folate and of folate levels on
B12. If evidence for a casual effect is identified, we planed
to use two-step MR37 to investigate whether there was evi-
dence that one maternal exposure mediates the relation-
ship between the other and offspring birthweight.
Follow-up analysis of gestational duration
Gestational duration is a major determinant of birth-
weight. Since gestational duration was unavailable for
>85% of individuals in the GWAS of birthweight,23 it is
possible that a causal relationship between maternal B12
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or folate and birthweight could be driven by a relationship
with gestational duration. Therefore, we performed a two-
sample IVW MR analysis to estimate the causal effect of
maternal B12 and folate levels on gestational duration. We
obtained summary results data from the latest maternal
GWAS study of gestational duration of 43 568 women of
European ancestry from 23andMe, presented in Zhang
et al.38 For the fetal GWAS of gestational duration, we
obtained summary results data from the latest EGG
Consortium study of 84 689 individuals.39 For the B12
analysis, the MMACHC SNP rs12272669 was not avail-
able in the maternal or fetal gestational duration GWAS
(and no SNPs in high LD (R2 >0.8) were available), leav-
ing a total of nine SNPs for analysis. The effect allele fre-
quencies were not available in the publicly available
summary results data from the fetal GWAS of gestational
duration, so we removed the MMAA SNP, rs2270665,
from the B12 analysis as it is a palindromic SNP and we
could not confirm that the direction of effect was the same
as in the B12 summary statistics. We conducted sensitivity
analysis using MR Egger regression,27 weighted median,30
simple and weighted mode estimation31 to adjust for any
potentially pleiotropic SNPs. Similar to the birthweight
analysis, we caution the interpretation of the folate sensi-
tivity analyses, due to the small number of SNPs available.
Checking SNP associations with B12 and folate
levels in pregnant women from the Exeter Family
Study of Childhood Health study
We performed an association analysis of the SNPs associ-
ated with B12/folate and the serum level of the two vita-
mins, measured at 28 weeks of gestation40 in a total of 871
pregnant women from the Exeter Family Study of
Childhood Health (EFSOCH).41 Genome-wide genotyping
and imputation in this study have been described previ-
ously.42 The outcome variables were inverse-normal trans-
formed before analysis, and the linear regression analysis
was adjusted for maternal age and five ancestry principal
components. The rs12272669 variant in the MMACHC
gene was not available, so rs11234541 in high LD
(r2¼0.9421 in CEU) was used as a proxy. This SNP had
low imputation quality in the EFSOCH study
(INFO¼ 0.68), and the results should be interpreted with
care.
Informed consent
Only publicly available summary results data were used in
the birthweight MR analyses. Participants in EFSOCH
gave informed consent, and ethical approval was obtained
from local review committee. 23andMe data (used in the
maternal gestational age analysis) were collected in compli-
ance with all applicable laws, from human subjects under
an Institutional Review Board-approved protocol in accor-
dance with US federal guidelines for ‘Protection of Human
Subjects’, and the 23andMe activities described herein fall
within the scope of the approved protocol. Only aggregate,
anonymized data were provided from 23andMe for analy-
sis in this study.
Results
The 10 variants included in the MR analysis of maternal
serum B12 levels explained 5.24% of the variance in serum
B12 concentrations in the original GWAS (3.82% without
the FUT2 variant, rs602662). The four variants included
in the MR analysis of maternal folate levels explained
1.3% of the total variation in serum folate concentration
in the original GWAS. F statistics for individual SNPs
ranged from 35 to 623 for B12 and from 48 to 203 for fo-
late levels. The magnitude of the SNP effects on serum B12
and folate concentrations measured in pregnant women
from the EFSOCH study were consistent with those from
the original GWAS (Supplementary Figures S1 and S2,
available as Supplementary data at IJE online), apart from
the MMACHC variant, rs12272669, which appeared to
have little effect in pregnant women at 28 weeks of gesta-
tion (heterogeneity P¼ 0.0002). However, we used a
proxy for this variant in the EFSOCH study, rs11234541,
which was in high LD with rs12272669 but had low impu-
tation quality.
The causal effect estimates of maternal and fetal B12
and folate levels on birthweight from the IVW analysis and
sensitivity analyses are shown in Table 1. We found no evi-
dence for a causal effect of maternal B12 levels on off-
spring birthweight [0.009 SD change in birthweight per 1
SD higher B12 (SEIVW¼ 0.012), PIVW¼ 0.469; Figure 1],
or of fetal B12 levels on their own birthweight [0.012 SD
change in birthweight per 1 SD higher B12
(SEIVW¼ 0.017), PIVW¼ 0.478; Supplementary Figure S3,
available as Supplementary data at IJE online]. The effect
estimates were similar when excluding the FUT2 variant,
rs602662 (Supplementary Table S4, available as
Supplementary data at IJE online).
We found evidence of a positive causal effect of mater-
nal folate levels on offspring birthweight [0.146 SD change
in birthweight per 1 SD higher folate (SEIVW¼ 0.041),
PIVW¼ 4x10-4; Figure 2]. Furthermore, we identified a neg-
ative effect of fetal folate levels on their own birthweight,
although the effect size was nearly a third of the maternal
folate causal effect estimate [0.051 SD change in birth-
weight per 1 SD higher folate (SEIVW¼ 0.025),
PIVW¼ 0.037; Supplementary Figure S4].
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There was evidence of heterogeneity in the causal effect
estimates of fetal B12 levels on their own birthweight
across the individual SNPs (Q¼27.790, P¼0.001), but no
strong evidence of heterogeneity in the causal effect esti-
mates of maternal B12 levels on offspring birthweight
(Q¼ 12.486, P¼ 0.162). To investigate the heterogeneity
further, we performed leave-one-out analysis of fetal B12
levels on their own birthweight (Supplementary Table S5,
available as Supplementary data at IJE online). As indi-
cated by the heterogeneity test, there was some variability
in the causal estimates, particularly when leaving the
MMACHC SNP, rs12272669, or the FUT2 SNP,
rs602662, out of the analysis. Even though there are no
known pleiotropic pathways for the MMACHC gene, we a
priori expected the FUT2 gene to have pleiotropic
effects.35,36 The causal effect estimates of maternal folate
Table 1 Mendelian randomization estimates of the causal effect of folate and vitamin B12 levels on birthweight. We estimated
causal effects for maternal folate and B12 levels on offspring birthweight (Maternal) and offspring’s folate and B12 levels on
their own birthweight (Fetal). Causal effects are estimated using five MR models: inverse variance weighted (IVW), weighted
median, simple mode, weighted mode and MR Egger regression. Causal effect estimates are the difference in mean birthweight












Inverse variance weighted 4 0.1459 0.0413 0.0004 10 0.0088 0.0121 0.4694
Weighted median 4 0.1443 0.0339 2.04 x 1005 10 0.0114 0.0138 0.4078
Simple mode - – – – 10 0.0041 0.0189 0.8348
Weighted mode - – – – 10 0.0058 0.0135 0.6782
MR Egger 4 0.4378 0.1507 0.1009 10 0.0031 0.0210 0.8852
Fetal:
Inverse variance weighted 4 0.0514 0.0247 0.0372 10 0.0118 0.0166 0.4776
Weighted median 4 0.0516 0.0269 0.0548 10 0.0031 0.0127 0.8068
Simple mode - – – – 10 0.0069 0.0220 0.7612
Weighted mode - – – – 10 0.0027 0.0138 0.8504
MR Egger 4 0.0536 0.1266 0.7135 10 0.0012 0.0291 0.9686
1 SD in birthweight correspond to 484 g.23
B12: vitamin B12; SNP: single nucleotide polymorphism; SE: standard error.
Figure 1 Mendelian randomization estimates of the causal effect of maternal B12 levels on offspring birthweight. The x-axis shows the single nucleo-
tide polymorphism (SNP) effect, and standard error, on vitamin B12 levels for each of the 10 SNPs, and the y-axis shows the SNP effect, and standard
error, on offspring birthweight. The regression line for the inverse variance weighted Mendelian randomization method is shown
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levels on offspring birthweight across the individual SNPs
also showed some heterogeneity (Q¼ 6.904, P¼ 0.075),
but no evidence for the fetal folate levels (Q¼ 0.018,
P¼ 0.999). To investigate the potential influence of the
SNPs in LD in the MTHFR gene and potential heterogene-
ity identified for the maternal folate levels, we performed a
leave-one-out analysis on both maternal and fetal folate
levels on birthweight (Supplementary Table S6, available
as Supplementary data at IJE online). When the MTHFR
SNP rs1801133 was excluded from the analysis, the causal
effect was attenuated for the effect of maternal folate levels
(0.099, SE¼ 0.051, P¼ 0.051), but stayed the same and
for fetal folate levels (0.051, SE¼ 0.034, P¼0.132).
There was no evidence of directional pleiotropy from
the MR Egger regression analysis for either B12 or folate
levels on birthweight (Egger intercept for maternal B12 lev-
els ¼ 0.003, P¼ 0.500; Egger intercept for fetal B12 levels
¼ 0.002, P¼0.662; Egger intercept for maternal folate
levels ¼ 0.028, P¼0.187; Egger intercept for fetal folate
levels ¼ 0.000, P¼0.988), although again highlighting
that the MR Egger result from the folate analysis would be
unreliable due to the small number of SNPs. This is further
supported by the low I2GX of 0.83 for the folate analysis,
which is below the suggested cut-off of 0.9, suggesting that
the MR Egger results could be influenced by measurement
error or weak instrument bias. Bowden’s I2GX was 0.98 for
B12, suggesting little influence in the MR Egger analyses
from measurement error or weak instrument bias.
We were unable to detect evidence for a causal effect of
B12 levels on folate levels in the two Danish cohorts
(Supplementary Table S7, available as Supplementary data
at IJE online), indicating that maternal folate levels are un-
likely to mediate a relationship between maternal B12 lev-
els and offspring birthweight. In the IVW analysis, we
detected a small causal effect of folate levels on B12 levels
in the two Danish cohorts (0.155 SD change in B12 per 1
SD higher folate (SEIVW¼0.077), PIVW¼ 0.043;
Supplementary Table S8, available as Supplementary data
at IJE online). However, given there is no evidence of a
causal effect of maternal B12 levels on offspring birth-
weight, it is unlikely that B12 levels mediate the relation-
ship between maternal folate levels and offspring
birthweight.
Last, we did not find any evidence of a causal effect of
maternal or fetal B12 or folate levels on gestational dura-
tion (Table 2). There was no evidence of directional plei-
otropy from the MR Egger regression analysis or of
heterogeneity between the causal estimates at each SNP
(Maternal: Directional Pleiotropy: PB12¼ 0.28,
PFolate¼ 0.87; Heterogeneity: PB12¼ 0.08, PFolate¼ 0.63;
Fetal: Directional pleiotropy: PB12¼ 0.59, PFolate¼ 0.38;
Heterogeneity: PB12¼ 0.12, PFolate¼ 0.21).
Discussion
We did not find any evidence for a causal effect of mater-
nal B12 levels on offspring birthweight [0.009 (0.015,
0.033) SD change in birthweight per 1 SD higher B12, cor-
responding to a 4 g increase (7 g, 16 g) in birthweight per
1 SD higher B12], nor was there evidence that fetal B12
levels influenced their own birthweight. The results were
consistent across the different sensitivity methods applied,
Figure 2 Mendelian randomization estimates of the causal effect of maternal folate levels on offspring birthweight. The x-axis shows the single nucle-
otide polymorphism (SNP) effect, and standard error, on folate levels for each of the four SNPs, and the y-axis shows the SNP effect, and standard er-
ror, on offspring birthweight. The regression line for the inverse variance weighted Mendelian randomization method is shown
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including the analyses with or without the FUT2 variant.
In contrast, we found evidence of a positive causal effect of
maternal folate levels on offspring birthweight [0.146
(0.065, 0.227) SD change in birthweight per 1 SD higher
folate, which corresponds to an increase in birthweight of
71 g (31 g, 110 g) per 1 SD higher folate]. Although we
could not detect any evidence for directional pleiotropy or
heterogeneity in these analyses, we have limited capacity to
test this due to having only four SNPs associated with fo-
late. We also found some evidence of an inverse effect of
fetal folate levels on their own birthweight [0.051
(0.100, 0.003) SD change in birthweight per 1 SD
higher folate, corresponding to a 25 g [48 g, 1 g] de-
crease in birthweight per 1 SD higher folate).
Previous multivariable regression association studies in-
vestigating the relationship between maternal B12 levels
and offspring birthweight have been inconsistent.7
Nevertheless, these studies are all relatively small (samples
sizes from 51 to 5577 in the meta-analysis presented by
Rogne and colleagues7) and therefore the effect size esti-
mates from the multivariable regression analyses between
maternal B12 levels and offspring birthweight had large
confidence intervals. In addition, the meta-analysis com-
bining the results from 12 studies found no evidence of an
association between maternal B12 levels and offspring
birthweight (N¼ 9406), with an estimate similar to the
results of our MR analysis [5.1 g (10.9 g, 21.0 g) change
in birthweight per 1 SD increase in maternal B12 levels].
Multivariable regression association studies and MR have
different assumptions and sources of bias; however, with
regards to maternal B12 levels on offspring birthweight,
the effect estimates in the meta-analysis of multivariable
regression analyses and our MR are similar, providing ad-
ditional confidence in our result. In the meta-analysis,
Rogne and colleagues7 observed some heterogeneity be-
tween the studies (I2 ¼ 30%),7 which was driven by an as-
sociation between B12 deficiency and birthweight in low-
and middle-income countries. They suggested that this as-
sociation could be explained by preterm birth rather than
reduced fetal growth; however, we did not see any evi-
dence for this in our MR analysis with gestational dura-
tion. Notably, one of the 10 SNPs from the birthweight
analysis was not available for the MR analysis estimating
the causal effect of maternal B12 levels on gestational du-
ration. There could be several reasons why we were unable
to find any evidence of an effect of B12 levels on offspring
birthweight within the normal range. First, there could be
a weak effect that we were unable to detect with the cur-
rent statistical power of our study. Second, folate defi-
ciency can be induced by a B12 deficiency,17 so there may
be a stronger effect of maternal B12 deficiency on offspring
birthweight than maternal B12 levels within the normal
range. As such, monitoring both B12 and folate levels dur-
ing pregnancy might be important.
Consistent with previous multivariable regression asso-
ciation studies8 and randomized controlled trials
(RCTs),14 our MR study suggests a causal effect of higher
maternal folate levels on increased offspring birthweight.
Table 2 Causal effect estimates of maternal folate and vitamin B12 levels on gestational duration. Causal effects are estimated
using five MR models: inverse variance weighted (IVW), weighted median, simple mode, weighted mode and MR Egger regres-
sion. Causal effect estimates are the difference in mean gestational duration [in days for the maternal effect and standard devia-












Inverse variance weighted 4 0.0772 0.1065 0.4685 9 0.0683 0.0725 0.3457
Weighted median 4 0.1248 0.1261 0.3225 9 0.0993 0.0748 0.1844
Simple mode – – – – 9 0.1760 0.1349 0.2281
Weighted mode – – – – 9 0.1171 0.0885 0.2222
MR Egger 4 0.1742 0.5498 0.7813 9 0.2231 0.1512 0.1836
Fetal:
Inverse variance weighted 4 0.0233 0.0459 0.6101 8 0.0132 0.0195 0.5007
Weighted median 4 0.0700 0.0475 0.1407 8 0.0194 0.0212 0.3595
Simple mode – – – – 8 0.0171 0.0347 0.6363
Weighted mode – – – – 8 0.0279 0.0270 0.3362
MR Egger 4 0.2572 0.2561 0.4209 8 0.0354 0.0444 0.4557
B12: vitamin B12; SNP: single nucleotide polymorphism; SE: standard error.
aNote that these estimates are not maternal- and fetal-specific estimates derived from conditional analyses.







niversity of Exeter user on 16 February 2021
Our MR analysis goes one step further than the multivari-
able regression studies and RCTs, as we have used serum
levels of folate, whereas the previous studies were based on
the use of folic acid supplements in pregnancy without
quantifying the downstream effect that those supplements
have on serum levels.8,14 We found a potential negative
causal effect of fetal folate levels, as proxied by the fetal ge-
notype, on their own birthweight, although the effect size
was only about a third of the positive effect of maternal fo-
late levels on offspring birthweight. The mechanism un-
derlying this effect is unclear, as folate is actively
transported across the placenta by folate transporters,
and not produced by the fetus.43,44 However, folate is
metabolized into the active forms both in the mother and
in the fetus, so this negative causal effect might indicate
that fetal folate metabolism is important. There were
only four SNPs included in the folate analysis, three of
which are located in the same gene, which was not
enough to obtain reliable sensitivity analyses, as partly
indicated by the I2GX of 0.83 for the MR Egger regres-
sion. Furthermore, the variant rs1801133 in the MTHFR
gene has been associated with diastolic blood pressure,
which is also known to causally influence birthweight23
and could therefore indicate potentially pleiotropic path-
ways [Causal effect estimate from the leave-one-out
analysis removing rs1801133: 48 g (0 g, 96 g) increase in
birthweight per 1 SD higher folate].
We did not find any evidence of a causal effect of
maternal or fetal folate levels on gestational duration,
suggesting that our finding of a causal effect of maternal
folate levels on offspring birthweight cannot be attributed
to gestational duration. However, the sample size in the
gestational duration GWAS (Maternal: N¼ 43 568;
Fetal: N¼ 84 689) was smaller than the GWAS of birth-
weight (N¼ 297 356 individuals reporting their own
birthweight and 210 248 women reporting their off-
spring’s birthweight) and the maternal SNP effect esti-
mates on gestational duration were not conditioned on
fetal genotype.
It is important to examine the findings of a causal rela-
tionship between folate and birthweight within the bigger
picture. Given that low maternal folate levels during
pregnancy are known to cause neural tube defects,45 we
would obviously not argue for stopping the widespread
recommendation and use of folic acid supplements during
pregnancy and the fortification of foods. Indeed, based
on our results, folic acid supplementation and fortifica-
tion of foods may have contributed to the observed in-
crease in birthweight and reduction of babies born small
for gestational age seen over the past few decades (23 g to
46 g, in a 9–18-year time span).46–48
Strengths and limitations
One of the strengths of our study was the ability to use the
partitioned maternal and fetal genetic effects from the larg-
est GWAS of birthweight (N¼ 297 356 individuals report-
ing their own birthweight and 210 248 women reporting
their offspring’s birthweight) in a two-sample MR ap-
proach to estimate the effect of maternal B12 and folate
levels on offspring birthweight, independent of any direct
fetal effect. We performed a series of sensitivity analyses to
explore potential bias due to horizontal pleiotropy, includ-
ing comparing findings for B12 levels with and without the
FUT2 genetic instrument which has been shown to have
pleiotropic effects. However, we acknowledge that the
methods used for the sensitivity analyses work best with
more SNPs than we had available in our analyses. For fo-
late, the I2GX of 0.83, below the suggested cut-off of 0.9,
indicates that the MR Egger results could be influenced by
measurement error or weak instrument bias.
An important limitation with this study is that the folate
and vitamin B12 levels measured and used in the exposure
GWAS were from non-pregnant women, as well as men.
However, we were able to check that the instruments were
valid in a pregnant population by performing an associa-
tion analysis in the EFSOCH study. We found no evidence
of different effect sizes in pregnant women compared with
the exposure GWAS used in these analyses, except for in
the rs12272669 variant in the MMACHC gene. The proxy
SNP we used in the EFSOCH study, rs11234541, had low
imputation quality, and as such the results should be inter-
preted with care.
Last, it is important to note that even though we did not
find any effect of maternal B12 levels on offspring birth-
weight, that does not mean that B12 levels do not have an
effect on the development of the fetus. B12 levels could in-
fluence growth in a particular period of the pregnancy, af-
fect a particular organ or growth of fat, lean or skeletal
tissue in different directions, which may not be reflected in
an outcome such as birthweight.
Conclusion
In conclusion, evidence is lacking for a causal relationship
of maternal vitamin B12 levels on offspring birthweight,
indicating that the association detected in previous multi-
variable regression association studies may have been due
to confounding. We found evidence for a causal effect of
higher maternal folate levels increasing offspring birth-
weight, which is consistent with previous multivariable re-
gression association studies and RCTs.
The data underlying the main Mendelian randomiza-
tion analysis in this manuscript are available at http://
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doi.org/10.1371/journal.pgen.1003530 (B12 and Folate
GWAS) and [https://doi.org/10.1038/s41588-019-0403-1]
(Birth-weight GWAS). The data underlying the gestational
age analysis were provided by 23andMe. Data may be
shared on request to 23andMe. Requests for access to the
original EFSOCH dataset should be made in writing in the
first instance to the EFSOCH data team via the Exeter
Clinical Research Facility [crf@exeter.ac.uk].
Supplementary data
Supplementary information is available at IJE online.
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